Furthermore, through bioinformatics analysis (Figure S1C) and the miR mimic approach (Figure 4G–I and Figure 5A,B), we identified RAF1 as the downstream target of miR-7-5p in inhibiting GBM progression. This evidence concerns the gene RAF1 and glioblastoma.